hsa_circ_0001947 Suppresses Acute Myeloid Leukemia Progression Via Targeting hsa-miR-329-5p/CREBRF axis

F Han, C Zhong, W Li, R Wang, C Zhang, X Yang… - …, 2020 - Taylor & Francis
F Han, C Zhong, W Li, R Wang, C Zhang, X Yang, C Ji, D Ma
Epigenomics, 2020Taylor & Francis
Aim: Accumulating evidence has indicated that circular RNAs (circRNAs) are involved in
cancer biology. However, their roles in acute myeloid leukemia (AML) remain unclear.
Therefore, we aimed to define novel circRNAs involved the development and progression of
AML. Materials & methods: We used circRNAs microarray to determine the differential
expression profile. Quantitative reverse transcription PCR analyzed the expression of
hsa_circ_0001947. The siRNA assesses the function of hsa_circ_0001947 in vitro and in …
Aim
Accumulating evidence has indicated that circular RNAs (circRNAs) are involved in cancer biology. However, their roles in acute myeloid leukemia (AML) remain unclear. Therefore, we aimed to define novel circRNAs involved the development and progression of AML.
Materials & methods
We used circRNAs microarray to determine the differential expression profile. Quantitative reverse transcription PCR analyzed the expression of hsa_circ_0001947. The siRNA assesses the function of hsa_circ_0001947in vitro and in vivo. A dual-luciferase and mimics/inhibitor were to determine the target gene relationship.
Results
hsa_circ_0001947 functions as a tumor inhibitor to suppress AML cell proliferation through hsa-miR-329-5p/CREBRF axis.
Conclusion
hsa_circ_0001947 may be as a novel potential biomarker for the treatment of AML.
Taylor & Francis Online